Mitsubishi Tanabe Looks To Maximize Generic Sales Through New Unit
This article was originally published in PharmAsia News
Executive Summary
Osaka-based Mitsubishi Tanabe Pharma plans to launch Tanabe Pharmaceutical sales company on April 1. Established on the basis of the company's current marketing division, Tanabe Pharmaceutical Trading, the new company will market MTP's 14 generic drugs with a plan to expand to 60-140 drugs and a sales goal of ¥10 billion. MTP focuses its generic drug business on circulatory and digestive pharmaceutical products. (Click here for more - Japanese language